An act relating to continuing the Psychedelic Therapy Advisory Working Group

This bill extends the Psychedelic Therapy Advisory Working Group's term and expands its membership and responsibilities. The group will continue reviewing research on psychedelics for mental health treatment, monitor other states' programs, and develop a pilot project for psilocybin therapy in serious illness and end-of-life care. It must submit a report by November 15, 2025, to legislative committees before potential future action. The bill does not change current laws but supports further study to inform future policy decisions.